In the last trading session, 1.16 million shares of the IN8bio Inc (NASDAQ:INAB) were traded, and its beta was -0.01. Most recently the company’s share price was $0.31, and it changed around -$0.03 or -9.25% from the last close, which brings the market valuation of the company to $22.11M. INAB currently trades at a discount to its 52-week high of $2.48, offering almost -700.0% off that amount. The share price’s 52-week low was $0.22, which indicates that the current value has risen by an impressive 29.03% since then. We note from IN8bio Inc’s average daily trading volume that its 10-day average is 0.96 million shares, with the 3-month average coming to 1.16 million.
IN8bio Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.40. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended INAB as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. IN8bio Inc is expected to report earnings per share of -0.08 for the current quarter.
IN8bio Inc (NASDAQ:INAB) trade information
Instantly INAB has showed a red trend with a performance of -9.25% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.3600 on recent trading dayincreased the stock’s daily price by 13.89%. The company’s shares are currently down -77.90% year-to-date, but still down -4.45% over the last five days. On the other hand, IN8bio Inc (NASDAQ:INAB) is -11.23% down in the 30-day period. We can see from the shorts that 1.0 million shares have been sold at a short interest cover period of 0.51 day(s).
IN8bio Inc (INAB) estimates and forecasts
IN8bio Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -78.21 percent over the past six months and at a 44.00% annual growth rate that is well above the industry average of 17.10%.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -50.62%.
INAB Dividends
IN8bio Inc’s next quarterly earnings report is expected to be released in January.
IN8bio Inc (NASDAQ:INAB)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 21.56% of IN8bio Inc shares, and 46.46% of them are in the hands of institutional investors. The stock currently has a share float of 59.23%. IN8bio Inc stock is held by 29.0 institutions, with AIGH CAPITAL MANAGEMENT LLC being the largest institutional investor. By 2024-06-30, it held 4.9157% of the shares, which is about 2.13 million shares worth $1.8 million.
VANGUARD GROUP INC, with 3.2892% or 1.42 million shares worth $1.21 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
